MYDCENTRAL / PHARMA COMMERCIAL AUTOMATION

Operations overview

Asterfield Pharma Group · fictional B2B pharma operator
SYNTHETIC SANDBOX
Agentic workflow platform

Complete the work between your systems.

From customer inquiries to evidence-backed quotations, gated approvals, order handoff and follow-ups. Every action is visible and auditable. No autonomous regulated quality decisions.

Priority commercial queue

What the agents actually complete

01
Collect and structure
RFQ email, attachments, product and commercial details
02
Check source records
Account, product, market, price, supply and document metadata
03
Route and resolve exceptions
Request planner, QA or commercial review only when needed
04
Execute approved handoffs
Simulated quote, customer acknowledgment and ERP draft
05
Verify the outcome
Track statuses, cycle time, audit events and pending actions

Example workflow chain

Customer inquiry→ Validation→ Approvals→ Quote sent→ Accepted PO→ ERP draft

Open a synthetic RFQ and run the steps. Cases include stock shortfall, controlled document requests, restricted account and duplicate requests.

Why this is not just another dashboard

The goal is fewer manual touches: retrieving records, compiling a quote, routing authorizations, preparing customer communication, matching the customer's PO and reconciling outcomes. Forecasting and reporting support decisions, but completed approved work is the product.

Inbound RFQs

5 synthetic scenarios
RFQCustomerProductStatus

Selected inquiry

Execution timeline ·

Run each step to see what a production agent would need to verify before preparing a quotation.

Normalized customer data

Policy findings

Run activity

Approval workspace

Policy-controlled authority

Only the corresponding role can approve its proposal. Commercial approval never overrides an eligibility block, a supply hold or document release restrictions.

Commercial Manager
Pricing, quantity, quote validity and commercial terms
Supply Planner
Backorder options and nonbinding supply confirmation
QA / Regulatory
Controlled document release request; formal release remains in the validated source workflow
Restricted-account and duplicate scenarios are intentionally blocked. The prototype does not offer a bypass for those holds.

Quote, customer acceptance and ERP handoff

Customer correspondence and follow-ups

Simulated correspondence ledger

Fictional monthly RFQ volume by week

Example values are illustrative, not customer production analytics.

ROI estimator

Model potential administrative capacity value; does not claim realized cash savings.

What we actually measure in a paid pilot

Time to completed outcome

Hands-on minutes from inbound RFQ to approved, accurately sent response; include rework.

Correctness

Field extraction accuracy, policy failures, quote/PO mismatches and duplicate prevention.

Closure

Automated touch reduction, quote acknowledgment, aging, exception clearance and order handoff.

Candidate system integrations

No systems connected

These are supported product targets, not claims about any specific pharma company's installed systems or permissions. Customer-by-customer technical discovery is mandatory.

Product guardrails

✓ Tenant-specific access control; minimum scopes
✓ Deterministic pricing calculations and account checks
✓ Human approval before external communications or ERP writes
✓ Evidence-linked extraction and durable audit trail
✓ Failure recovery, idempotency and customer-specific SOPs

Not in the initial scope

No autonomous batch disposition, GMP release, regulatory claims, clinical judgment or regulated electronic signatures.
Not a replacement for SAP, Salesforce, Veeva or a validated QMS.
No real credential handling or live connections are implemented in this local demo.
Regulatory classification depends on intended use; customer QA/legal approval before production.